Collie, Western Australia, May 5, 2026 – (ACN Newswire) – Holista Colltech Limited (Holista; ASX: HCT) is delighted to reveal that it has actually participated in a binding Joint Venture Agreement with Swang Chai Chuan Limited (SCC; HKEX: 2321) for the financing, advancement and operation of an ovine nano-collagen production center in Collie, Western Australia.
Secret Commercial Terms
The Joint Venture (JV) will run through Ovicoll Pty Ltd, with a preliminary ownership structure of 50:50 in between Holista and SCC.
SCC will contribute RM5,000,000 (roughly A$ 1.6 million) to money commissioning and preliminary operating capital requirements of the JV.
As part of the business regards to the JV, Holista will pay comparable to 3% per year on SCC’s preliminary financing contribution for a duration of 2 years.
Holista maintains a legal choice to increase its interest in the JV to 75%, exercisable in between the 2nd and 5th anniversaries of SCC’s preliminary capital contribution, based upon a pre-agreed evaluation method.
In connection with the JV, Dr. Rajen Manicka, a considerable investor of the Company, has actually supplied an individual warranty in favour of SCC in regard of specific monetary commitments of the JV. This assurance is protected by the shares he keeps in Holista and is offered in his individual capability. The warranty does not make up a responsibility of the Company.
Operations and Governance
Holista will be accountable for the daily management and operation of the JV. The Board of Ovicoll Pty Ltd will consist of an equivalent variety of directors selected by Holista and SCC.
Copyright and Commercial Terms
Holista will keep ownership of all pre-existing and recently established copyright, with the JV approved a licence to use this innovation for its organization.
The JV will pay Holista a royalty of 8% of gross sales, topped at 20% of the JV’s earnings before tax.
Strategic Rationale
The Joint Venture represents a considerable action in the commercialisation of Holista’s collagen innovation and supports the Company’s technique to develop scalable production abilities and broaden into global markets.
The Collie center is anticipated to supply a platform to produce high-value nano-collagen items for usage in nutraceutical, food, cosmetic, and biomedical applications.
SCC is anticipated to play an active function in supporting the Joint Venture’s market advancement activities, leveraging its local network and experience in circulation and customer markets to assist in item commercialization.
Extra Information
There are no product conditions precedent to the Joint Venture Agreement.
The Company will supply more updates on advancement turning points and timing of commissioning in due course.
This statement has actually been authorized by the Board of Holista Colltech Limited.
About Holista Colltech Limited
Holista Colltech Limited (ASX: HCT) is a Perth-based innovator in health and health options, noted on the Australian Securities Exchange. The Company runs throughout 4 core company departments: Dietary Supplements, Healthy Food Ingredients, Ovine Collagen, and Infection Control Solutions.
Holista’s portfolio consists of market-leading dietary supplements, trademarked low-GI food active ingredients embraced by international food producers, premium disease-free ovine collagen, and natural, non-toxic sanitizers for customer and commercial usage. These offerings show Holista’s dedication to integrating the very best of nature and science to support much healthier modern-day way of lives.
With a strong performance history of research study, advancement, and commercialization, Holista has actually originated numerous exclusive innovations in the worldwide health and health sector. The Company stays devoted to providing sustainable, science-backed options that improve lives and promote much better living worldwide.
